A novel diagnostic model using machine learning (ML).
Lusaris Therapeutics: From Promising Psychedelic Startup to Vanishing Act | Psychedelic Invest
In November 2022, Lusaris Therapeutics made news for its $60 million Series A round. Since then, there has been a curious silence from the company.